SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

FDA Approves Sanofi’s Infilbray for Gaucher Disease Type 3 Symptoms

The FDA approved Sanofi’s Infilbray for neurological symptoms of Gaucher disease type 3.

Related stories